microbiology
Navigation Links
microbiology at biology products
DASGIP BioBlock from DASGIP AG
... performance agitation and temperature control for microbiology and cell culture. The BioBlock controls four wells independently and is suitable for DASGIP bioreactors from 150 mL to 1.5 L working volume. Its temperature ranges from approximately 10 °C to 60 °C . Each well is equipped with an individual e...DASGIP Process Control from DASGIP AG
...ystems fedbatch-pro® and cellferm-pro® for microbiology and cell culture. Dimension Processor Computer (W x L x H): 7.87” x 19.69” x 16.93” Dimension LCD (W x L x H): 16.34” x 8.6” x 17.3” Please consider that ranges in volumes, speed etc, can refer to versions or d......ystems fedbatch-pro® and cellferm-pro® for microbiology and cell culture. Dimensions (D x H): 1.77” x 7.48” Stirrer speed: 40 - 1250 rpm One overhead drive per vessel...Multi-Pump Module MP4 from DASGIP AG
...ystems fedbatch-pro® and cellferm-pro® for microbiology and cell culture. Dimensions (W x L x H): 11.9” x 12.6” x 7.5” Ambient conditions: 5 °C to 40 °C; max. 80 % rH Power Supply: typ. 45 VA at 230, 32 VA at 115 V Flow rates: 0.01 - 5 L/h Please consider that ranges in v...Multi-Pump Module MP8 from DASGIP AG
...ystems fedbatch-pro® and cellferm-pro® for microbiology and cell culture. Dimensions GA4 (W x L x H): 11.9” x 12.6” x 7.5” Permissive ambient conditions: 15 to 40 °C; max. 80 % rH Power Supply: 60 VA Please consider that ranges in volumes, speed etc, can refer to versions or di......urella, Salmonella and Staphylococcus species. For microbiology pH~7 (2% in water)......me productions. From casein, pancreatic digest For microbiology pH6.8 0.5 at 25 C, 2% in water......le for work in histology, cytology, urinalysis and microbiology precleaned store at room temperature...Other ContentsherniatedherniatedgenitalgenitalgenitalgenitalgenitallabialissimplexsimplexsimplexsimplexsimplexsimplexherpesvirusherpesvirushistaminehistaminehistamineOther TagsPolishPolishActivistsForcepsEarthquakeAirwayAirway
(Date:9/4/2008)...hy is it that the origins of many serious diseases...a scientist at the University of California, San D... molecular view of the indivisible unit of life, t...ng findings from multiple disciplines, Jamey Marth...lecular Medicine and Investigator with the Howard ...
(Date:9/3/2008)...Vein Recognition Solution Named the Winner in the ...thcare Category, SUNNYVALE, Calif., Sept. 3 /PRNe...nc., a leading supplier of innovative computer pro...biometric security solutions, announced,today that...was named the,winner in the Best Security Solution...
(Date:9/3/2008)...GALVESTON, Texas University of Texas Medical Bran...biochemical link in the process by which the Ebola...ding a way to treat the deadly disease produced by...tal hemorrhagic fever in its victims and inflicts ...aks. No vaccine or antiviral therapy has been deve...
(Date:9/3/2008)...o City once topped lists of places with the worst ...rb emissions have improved the situation, tiny par...mospheric scientists from UC San Diego and six oth...hangs over the city to precisely identify aerosols... changes to the mix. , This forensic work will h...
Breaking Biology News(10 mins):Do 68 molecules hold the key to understanding disease? 2Fujitsu PalmSecure(TM) Wins Network Products Guide 2008 Reader Trust Award 2Fujitsu PalmSecure(TM) Wins Network Products Guide 2008 Reader Trust Award 3Scientists uncover Ebola cell-invasion strategy 2Smoke smudges Mexico City's air, chemists identify sources 2Smoke smudges Mexico City's air, chemists identify sources 3Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 1Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 2Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 3Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 4Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 5Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 6Dynavax and Merck 26 Co Inc Announce Partnership to Develop HEPLISAV 28TM 29 an Investigational Hepatitis B Vaccine Currently in Phase 3 5190 1Dynavax and Merck 26 Co Inc Announce Partnership to Develop HEPLISAV 28TM 29 an Investigational Hepatitis B Vaccine Currently in Phase 3 5190 2Dynavax and Merck 26 Co Inc Announce Partnership to Develop HEPLISAV 28TM 29 an Investigational Hepatitis B Vaccine Currently in Phase 3 5190 3Dynavax and Merck 26 Co Inc Announce Partnership to Develop HEPLISAV 28TM 29 an Investigational Hepatitis B Vaccine Currently in Phase 3 5190 4Dynavax and Merck 26 Co Inc Announce Partnership to Develop HEPLISAV 28TM 29 an Investigational Hepatitis B Vaccine Currently in Phase 3 5190 5Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam 5187 1Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam 5187 2US adults most likely to report medical errors and skip needed care due to costs 5183 1US adults most likely to report medical errors and skip needed care due to costs 5183 2US adults most likely to report medical errors and skip needed care due to costs 5183 3US adults most likely to report medical errors and skip needed care due to costs 5183 4(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2[0] New guide explores making the most of Social Security[0] Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development [0] Schofield Publishing Enters the Newsletter Market[0] ULURU Inc. to Present at the Thomas Weisel Partners Healthcare Conference 2008
UrologistsIcelandPolishActivistsAutoGenomicsCMPMedicaFASgenTravoltaEnriqueSadieRefugeesForcepsEarthquakeAirway
Other Tagscytokines 2cytokines 3banking 2reality 2bones 2bones 3bones 4bones 5measure 2measure 3measure 4measure 5measure 6measure 7measure 8measure 9measure 10made 2made 3made 4made 5made 6made 7made 8made 9made 10makes 2makes 3makes 4makes 5makes 6makes 7makes 8makes 9makes 10| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |